Sector: Healthcare | Industry: Healthcare Facilities & Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 262 N University Ave. FARMINGTON UT 84025 |
Tel: | N/A |
Website: | https://pacs.com |
IR: | See website |
Key People | ||
Jason Murray Chairman of the Board, Chief Executive Officer | Joshua Jergensen President, Chief Operating Officer | Mark Hancock Executive Vice Chairman of the Board |
Derick Apt Chief Financial Officer | Peter Sanford President, Providence Administrative Consulting Services, Inc. | Michelle Lewis Chief Accounting Officer |
Joseph Lee Chief Compliance Officer | John Mitchell Chief Legal Officer, Secretary |
Business Overview |
PACS Group, Inc. is a holding company investing in post-acute healthcare facilities, professionals, and ancillary services. The Company is focused on delivering skilled nursing care through a portfolio of independently operated facilities. It also provides its independently operated facilities with a comprehensive suite of technology, support, and back-office services. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company's independent subsidiaries operate about 284 post-acute care and senior living facilities across 16 states, serving over 27,000 patients daily. |
Financial Overview |
For the six months ended 30 June 2024, PACS Group Inc revenues totaled $1.92B. Net income totaled to $38.2M. |
Employees: | 32,433 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $5,043M as of Jun 30, 2024 |
Annual revenue (TTM): | N/A |
EBITDA (TTM): | N/A |
Net annual income (TTM): | N/A |
Free cash flow (TTM): | N/A |
Net Debt Last Fiscal Year: | $458.75M as of Jun 30, 2024 |
Shares outstanding: | 152,399,733 as of Jun 30, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |